Preparation and characterization of stable pH-sensitive vesicles composed of α-tocopherol hemisuccinate

AAPS PharmSciTech

Volumn 13, Issue 4, 2012, Pages 1377-1385

  Xu, Huan ^a   Deng, Yi Hui ^b   Wang, Kai Qian ^a   Chen, Da Wei ^b  

^a LIAONING NORMAL UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

cleavage; long circulation; PEG tocopherol hemisuccinate; pH sensitive; vesicles

Indexed keywords

ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL HEMISUCCINATE; CALCEIN; CALCIUM ION; CHOLESTEROL; MACROGOL; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CELL VACUOLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG SYNTHESIS; ENCAPSULATION; HYDROPHOBICITY; MALE; MEMBRANE FUSION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PKA; PRIORITY JOURNAL; STATIC ELECTRICITY; ZETA POTENTIAL;

ALPHA-TOCOPHEROL; ANIMALS; AREA UNDER CURVE; BUFFERS; CALCIUM; CHOLESTEROL; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FLUORESCEINS; HALF-LIFE; HYDROGEN-ION CONCENTRATION; LIPIDS; MALE; MICE; PARTICLE SIZE; POLYETHYLENE GLYCOLS; SERUM; SOLUTIONS;

EID: 84871649742     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9863-7     Document Type: Article

References (35)

1. Yamada K, Arita K, Kobuchi H, et al. Cholesteryl-hemisuccinate-induced apoptosis of promyelocytic leukemia HL-60 cells through a cyclosporin A-insensitive mechanism. Biochem Pharmacol. 2003;65:339-48.
2. Daleke DL, Hong K, Papahadjopoulos D. Endocytosis of liposomas by macrophages binding, acidification of leakage of liposomes monitored by a new fluorescence assay. Biochim Biophys Acta. 1990;1024:352-66.
3. Plageman PGW, Marz R, Wohlhueter RM. Transport and metabolism of deoxycytidine and 1-ß-D Arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation, and regulation of triphosphate synthesis. Cancer Res. 1978;38:978-89.
4. Drummond DC, Zignani M, Leroux JC. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res. 2000;39:409-60.
5. Gerweck LE, Seetharaman K. Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer. Cancer Res. 1996;56:1194-8.
6. Ellens H, Bentz J, Szoka FC. Proton- and calcium-induced fusion and destabilization of liposomes. Biochemistry. 1985;24:3099-106.
7. Turk MJ, Reddy JA, Chmielewski JA, et al. Low characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs. Biochim Biophys Acta. 2002;1559:56-68.
8. Straubinger RM, Duzgunes N, Papahadjopoulos D. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules. FEBS Lett. 1985;179:148-54.
9. Ge SR, Pei YY. Release mechanisms of pH sensitive liposomes. Chin J Pharm. 1998;29:564-8.
10. Torchilin V. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm. 2009;71:431-44.
11. Oliveira MC, Rosilio V, Lesieur P. pH-sensitive liposomes as a carrier for oligonucleotides: a physico-chemical study of the interaction between DOPE and a 15-mer oligonucleotide in excess water. Biol Chem. 2000;87:127-37.
12. Reddy JA, Low PS. Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation. J Contr Release. 2000;64:27-37.
13. Holland JW, Hui C, Cullis PR, Madden TD. Poly(ethylene glycol)-lipid conjugates regulate the calcium-Induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine. Biochemistry. 1996;35:2618-24.
14. Kirpotin D, Hong K, Mullah N, Papahadjopoulos D, et al. Liposomes with detachable polymer coating destabilization and fusion of dioleoylphosphatidylethanolamine vesicles triggered by cleavage of surface-grafted poly(ethylene glycol). FEBS Lett. 1996;388:115-8.
15. Zhang JX, Zalipsky S, Mullah N, et al. Pharmaco attributes of dioleoylphosphatidylethanolamine/cholesterylhemisuccinate liposomes containing different types of cleavable lipopolymers. Pharmacol Res. 2004;49:185-98.
16. Auguste DT, Armes SP, Brzezinska KR, et al. pH triggered release of protective poly(ethylene glycol)-b-polycation copolymers from liposomes. Biomaterials. 2006;27:2599-608.
17. Ducat E, Deprez J, Gillet A, et al. Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. Int J Pharm. 2011;420:319-32.
18. Oumzil K, Khiati S, Grinstaff MW, et al. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating. J Contr Release. 2011;151:123-30.
19. Janoff AS, Kurtz CL, Jablonski RL. Characterization of cholesterol hemisuccinate and α-tocopherol hemisuccinate vesicles. Biochim Biophys Acta. 1988;941:165-75.
20. Peschka R, Purmann T, Schubert R. Cross-flow filtration - an improved for the preparation of liposomes. Int J Pharm. 1988;162:177-83.
21. Xu H, Wang KQ, Deng YH, et al. Determination of entrapment efficiency of calcein liposomes using anion exchange resin minicolumn centrifugation-method. Chin J Pharm Anal. 2010;30:1713-6.
22. Xu H, Deng YH, Chen DW, et al. Esterase-triggered dePEGylation of CHST vesicles modified with cleavable PEG-lipids. J Contr Release. 2008;130:238-45.
23. Schurtenberger P, Mazer NKW. Micelle to vesicle transition in aqueous solutions of bile salt and lecithin. J Phys Chem. 1985;89:1042-9.
24. Ma YL, Wu YH, Zhao Y, et al. Study on synthesis and anticarcinogenic activities of vitamin E succinate. J Harbin Univ Commer Nat Sci. 2003;19:8-10.
25. Li HW, Wu K. Structural basis of α-tocopherol succinate as an antineoplastic agent. J Hygiene Res. 2004;33:512-4.
26. Sriwongsitanont S, Ueno M. Physicochemical properties of PEG-grafted liposomes. Chem Pharm Bull. 2002;50:1238-44.
27. Srinath P, Chary MG, Vyas SP, et al. Long-circulating liposomes of indomethacin in arthritic rats - a biodisposition study. Pharm Acta Helv. 2000;74:399-404.
28. Papisov MI. Theoretical considerations of RES-avoiding liposomes: molecular mechanics and chemistry of liposome interactions. Adv Drug Del Rev. 1998;32:119-38.
29. Roser M, Fischer D, Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur J Pharm Biopharm. 1998;46:255-63.
30. Woodle MC, Newman MS, Cohen JA. Sterically stabilized liposomes: physical and biological. J Drug Target. 1994;2:397-403.
31. Jizomoto H, Kanaoka E, Hirano K. pH-sensitive liposomes composed of tocopherol hemisuccinate and of phosphatidylethanolamine including tocopherol hemisuccinate. Biochim Biophys Acta. 1994;1213:343-8.
32. Shi GF, Guo WJ, Stephenson SM. Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations. J Contr Release. 2002;80:309-19.
33. Woodle MC, Collins CR, Sponsler E, et al. Sterically stabilized liposomes: reduction in electrophoretic mobility but not electrostatic surface potential. Biophys J. 1992;61:902-10.
34. Bedu-Addo FK, Huang L. Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery. Adv Drug Deliv Rev. 1995;16:235-47.
35. Zhou SH. How much time does a cycle of the body's blood circulation need? Biol Teach. 1994;7:45.